On the origins of SARS-CoV-2

Stakeholders in public health must lobby policy makers to make decisions based on evidence, not political expediency, particularly when the studies that hang in the balance are critical to understanding the origins of epidemics.

Saved in:
Bibliographic Details
Published inNature medicine Vol. 27; no. 1; p. 9
Main Author Rasmussen, Angela L.
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.01.2021
Nature Publishing Group
Subjects
631/326/1762
631/326/596/4130
706/648/453
Biomedical and Life Sciences
Biomedical Research
Biomedicine
Cancer Research
COVID-19
Genome, Viral
Humans
Infectious Diseases
Medical misconceptions
Metabolic Diseases
Molecular Medicine
Neurosciences
Origins
Public health
Research Support as Topic
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Social aspects
World View
United States
Online AccessGet full text

Cover

More Information
Summary:Stakeholders in public health must lobby policy makers to make decisions based on evidence, not political expediency, particularly when the studies that hang in the balance are critical to understanding the origins of epidemics.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
ISSN:1078-8956
1546-170X
DOI:10.1038/s41591-020-01205-5